| Dr Samerah G Razuman, MD | |
|
2000 Hartman Rd Ste 1, Fort Pierce, FL 34947-4412 | |
| (772) 465-1170 | |
| (772) 465-1171 |
| Full Name | Dr Samerah G Razuman |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 30 Years |
| Location | 2000 Hartman Rd Ste 1, Fort Pierce, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184672164 | NPI | - | NPPES |
| 107239500 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | ME0082363 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rai Care Centers - Port Saint Lucie | Port saint lucie, FL | Dialysis facility |
| St Lucie Medical Center | Port saint lucie, FL | Hospital |
| Lawnwood Regional Medical Center & Heart Institute | Fort pierce, FL | Hospital |
| Cleveland Clinic Martin North Hospital | Stuart, FL | Hospital |
| Raulerson Hospital | Okeechobee, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Samerah Razuman Md Pllc | 2769742808 | 3 |
| Mk Acharya Md Pa And Pm Reddy Md | 7012981350 | 53 |
News Archive
Abraxis BioScience, Inc. today announced that its randomized registrational Phase 3 clinical trial comparing ABRAXANE® (protein-bound paclitaxel) with Taxol® (paclitaxel) injection, both in combination with carboplatin, met the study's primary endpoint by demonstrating that ABRAXANE showed a significant improvement in overall response rate as compared to Taxol, in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), as assessed by independent radiologist review.
The following joint statement, by the National Coordinator for Health Information Technology, David Blumenthal, M.D., M.P.P., and the Centers for Medicare & Medicaid Services' Principal Deputy Administrator Marilyn Tavenner, was issued today at a forum, "Accelerating Electronic Health Records Adoption and Meaningful Use."
University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19.
Fluctuations in the unemployment rate affect people's health care choices, finds a new study in Health Services Research. Specifically, a one percent increase in state unemployment corresponded to a 1.58 percent reduction in the use of preventive health care services such as mammograms, pap tests, and annual check-ups.
› Verified 6 days ago
| Entity Name | Mk Acharya Md Pa & Pm Reddy Md |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780684795 PECOS PAC ID: 7012981350 Enrollment ID: O20040823001373 |
News Archive
Abraxis BioScience, Inc. today announced that its randomized registrational Phase 3 clinical trial comparing ABRAXANE® (protein-bound paclitaxel) with Taxol® (paclitaxel) injection, both in combination with carboplatin, met the study's primary endpoint by demonstrating that ABRAXANE showed a significant improvement in overall response rate as compared to Taxol, in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), as assessed by independent radiologist review.
The following joint statement, by the National Coordinator for Health Information Technology, David Blumenthal, M.D., M.P.P., and the Centers for Medicare & Medicaid Services' Principal Deputy Administrator Marilyn Tavenner, was issued today at a forum, "Accelerating Electronic Health Records Adoption and Meaningful Use."
University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19.
Fluctuations in the unemployment rate affect people's health care choices, finds a new study in Health Services Research. Specifically, a one percent increase in state unemployment corresponded to a 1.58 percent reduction in the use of preventive health care services such as mammograms, pap tests, and annual check-ups.
› Verified 6 days ago
| Entity Name | Samerah Razuman Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750803888 PECOS PAC ID: 2769742808 Enrollment ID: O20180209000207 |
News Archive
Abraxis BioScience, Inc. today announced that its randomized registrational Phase 3 clinical trial comparing ABRAXANE® (protein-bound paclitaxel) with Taxol® (paclitaxel) injection, both in combination with carboplatin, met the study's primary endpoint by demonstrating that ABRAXANE showed a significant improvement in overall response rate as compared to Taxol, in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), as assessed by independent radiologist review.
The following joint statement, by the National Coordinator for Health Information Technology, David Blumenthal, M.D., M.P.P., and the Centers for Medicare & Medicaid Services' Principal Deputy Administrator Marilyn Tavenner, was issued today at a forum, "Accelerating Electronic Health Records Adoption and Meaningful Use."
University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19.
Fluctuations in the unemployment rate affect people's health care choices, finds a new study in Health Services Research. Specifically, a one percent increase in state unemployment corresponded to a 1.58 percent reduction in the use of preventive health care services such as mammograms, pap tests, and annual check-ups.
› Verified 6 days ago
| Entity Name | Treasure Coast Nephrology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922645324 PECOS PAC ID: 9830524057 Enrollment ID: O20200116001738 |
News Archive
Abraxis BioScience, Inc. today announced that its randomized registrational Phase 3 clinical trial comparing ABRAXANE® (protein-bound paclitaxel) with Taxol® (paclitaxel) injection, both in combination with carboplatin, met the study's primary endpoint by demonstrating that ABRAXANE showed a significant improvement in overall response rate as compared to Taxol, in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), as assessed by independent radiologist review.
The following joint statement, by the National Coordinator for Health Information Technology, David Blumenthal, M.D., M.P.P., and the Centers for Medicare & Medicaid Services' Principal Deputy Administrator Marilyn Tavenner, was issued today at a forum, "Accelerating Electronic Health Records Adoption and Meaningful Use."
University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19.
Fluctuations in the unemployment rate affect people's health care choices, finds a new study in Health Services Research. Specifically, a one percent increase in state unemployment corresponded to a 1.58 percent reduction in the use of preventive health care services such as mammograms, pap tests, and annual check-ups.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samerah G Razuman, MD 2000 Hartman Road, Suite 1, Fort Pierce, FL 34950-4830 Ph: (772) 465-1170 | Dr Samerah G Razuman, MD 2000 Hartman Rd Ste 1, Fort Pierce, FL 34947-4412 Ph: (772) 465-1170 |
News Archive
Abraxis BioScience, Inc. today announced that its randomized registrational Phase 3 clinical trial comparing ABRAXANE® (protein-bound paclitaxel) with Taxol® (paclitaxel) injection, both in combination with carboplatin, met the study's primary endpoint by demonstrating that ABRAXANE showed a significant improvement in overall response rate as compared to Taxol, in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), as assessed by independent radiologist review.
The following joint statement, by the National Coordinator for Health Information Technology, David Blumenthal, M.D., M.P.P., and the Centers for Medicare & Medicaid Services' Principal Deputy Administrator Marilyn Tavenner, was issued today at a forum, "Accelerating Electronic Health Records Adoption and Meaningful Use."
University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19.
Fluctuations in the unemployment rate affect people's health care choices, finds a new study in Health Services Research. Specifically, a one percent increase in state unemployment corresponded to a 1.58 percent reduction in the use of preventive health care services such as mammograms, pap tests, and annual check-ups.
› Verified 6 days ago
Sabrina Marie Seus, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1700 South 23rd Street, Lawnwood Regional Medical Center, Fort Pierce, FL 34950 Phone: 772-467-8291 | |
Ms. Kirsten Alexandra Nathan, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1700 S 23rd St, Fort Pierce, FL 34950 Phone: 772-461-4000 | |
Dr. Perry R Lloyd Iii, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2207 Sunrise Blvd, Fort Pierce, FL 34950 Phone: 772-465-0491 Fax: 772-461-6360 | |
Mrs. Marcy Ann Studzinski, DO Nephrology Medicare: Medicare Enrolled Practice Location: 1900 Nebraska Avenue, Suite 9, Fort Pierce, FL 34950 Phone: 772-465-4499 Fax: 772-466-0832 | |
Mohammad Izhar, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2000 Hartman Rd Ste 1, Fort Pierce, FL 34947 Phone: 724-651-1707 Fax: 772-465-1171 | |
Mr. Kamalakar T Rao, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1900 Nebraska Avenue, Suite 9, Fort Pierce, FL 34950 Phone: 772-465-4499 Fax: 772-466-0832 |